OVERVIEW
The global In-Vitro diagnostic market size is expected to surpass USD 1,13,986 million by 2026 on account of COVID-19, growing at a CAGR of 4.90 percent over the forecast period. The COVID-19 pandemic turned the spotlight on in-vitro diagnostics, since there's an increasing demand for the IVD kits and reagents for the rapid and accurate diagnosis of SARS-CoV2 viral infection among the worldwide population. The outbreak of COVID-19 is predicted to positively impact the market studied, as in-vitro diagnostics involves testing of varied biological samples. this is often expected to assist the diagnosis of infectious diseases, like COVID-19.TABLE OF CONTENT
- 1.1 Study Objectives
- 1.2 Market Definition
- 1.3 Study Scope
- 1.3.1 Markets Covered
- 1.3.2 Geographic Scope
- 2 RESEARCH METHODOLOGY
- 2.1 Research Data
- 2.1.1 Secondary Data
- 2.1.1.1 Key Data From Secondary Sources
- 2.1.2 Primary Data
- 2.1.2.1 Key Data From Primary Sources
- 2.1.2.2 Key Industry Insights
- 2.1.2.3 Breakdown of Primaries
- 2.1.1 Secondary Data
- 2.2 Market Size Estimation
- 2.2.1 Bottom-Up Approach
- 2.2.2 Top-Down Approach
- 2.3 Market Breakdown and Data Triangulation
- 2.4 Research Assumptions
- 2.1 Research Data
- 3 Global In Vitro Diagnostics Market – Executive Summary
- 3.1 Market Revenue, Market Size and Key Trends by Company
- 3.2 Key Trends by type of Application
- 3.3 Key Trends segmented by Geography
- 4 Global In Vitro Diagnostics Market – Comparative Analysis
- 4.1 Product Benchmarking - Top 10 companies
- 4.2 Top 5 Financials Analysis
- 4.3 Market Value split by Top 10 companies
- 4.4 Patent Analysis - Top 10 companies
- 4.5 Pricing Analysis
- 5 Global In Vitro Diagnostics Market – Industry Market Entry Scenario
- 5.1 Regulatory Framework Overview
- 5.2 New Business and Ease of Doing business index
- 5.3 Case studies of successful ventures
- 5.4 Customer Analysis – Top 10 companies
- 6 Global In Vitro Diagnostics Market - Market Forces
- 6.1 Introduction
- 6.2 Market Dynamics
- 6.2.1 Drivers
- 6.2.2 Opportunities
- 6.2.3 Challenges
- 6.3 Porters Analysis of Market
- 6.3.1 Bargaining power of suppliers
- 6.3.2 Bargaining powers of customers
- 6.3.3 Threat of new entrants
- 6.3.4 Rivalry among existing players
- 6.3.5 Threat of substitutes
- 7 Global In Vitro Diagnostics Market - Strategic Analysis
- 7.1 Value Chain analysis
- 7.2 Supplier and distributor analysis (Market share and product dealing strategies)
- 8 Global In Vitro Diagnostics Market – By Product & Service (Market Size – & million/billion)
- 8.1 Reagents & Kits
- 8.2 Instruments
- 8.3 Data Management Software
- 8.4 Services
- 9 Global In Vitro Diagnostics Market - By Technology
- 9.1 Immunochemistry/Immunoassay
- 9.2 Hematology
- 9.3 Coagulation & Hemostasis
- 9.4 Molecular Diagnostics
- 9.5 Clinical Chemistry
- 9.6 Microbiology
- 9.7 Urinalysis
- 9.8 Others
- 10 Global In Vitro Diagnostics Market - By Application
- 10.1 Autoimmune Diseases
- 10.2 Drug Testing/Pharmacogenomics
- 10.3 Infectious Diseases
- 10.4 Cardiology
- 10.5 Diabetes
- 10.6 Nephrology
- 10.7 HIV/AIDS
- 10.8 Oncology/Cancer
- 10.9 Others
- 11 Global In Vitro Diagnostics Market - By End-User
- 11.1 Laboratories
- 11.2 Point-Of-Care Testing
- 11.3 Patient Self-Testing
- 11.4 Hospitals
- 11.5 Academics
- 11.6 Others
- 12 Global In Vitro Diagnostics Market – By Geography (Market Size – & million/billion)
- 12.1 Introduction
- 12.2 North America
- 12.2.1 US
- 12.2.2 Canada
- 12.2.3 Mexico
- 12.3 Europe
- 12.3.1 U.K
- 12.3.2 Germany
- 12.3.3 Italy
- 12.3.4 France
- 12.3.5 Spain
- 12.3.6 Rest of Europe
- 12.4 Asia-Pacific
- 12.4.1 China
- 12.4.2 Japan
- 12.4.3 India
- 12.4.4 South Korea
- 12.4.5 Rest of APAC
- 12.5 Rest of the World
- 12.5.1 South America
- 12.5.2 Middle East
- 12.5.3 Africa
- 13 Global In Vitro Diagnostics Market – Entropy
- 13.1 New product launches
- 13.2 M&A's, collaborations, JVs and partnerships
- 14 Global In Vitro Diagnostics Market Company Profile (Key Players)
- 14.1 Market Share, Company Revenue, Products, M&A, Developments
- 14.2 Abbott Laboratories, Inc.
- 14.3 Johnson & Johnson
- 14.4 Roche Diagnostics
- 14.5 Danaher Corporation
- 14.6 Agilent Technologies
- 14.7 Siemens AG
- 14.8 Becton, Dickinson and Company
- 14.9 Biomérieux Sa
- 14.10 Thermo Fisher Scientific
- 14.11 Bio-Rad Laboratories, Inc.
- 14.12 Company 11 & more
- 15 Global In Vitro Diagnostics Market - Appendix
- 15.1 Sources
- 15.2 Abbreviations
In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Application, by End Use, by Product, by Technology (Clinical Chemistry, Molecular Diagnostics), and Segment – 2022 to 2027
Category: HealthcareSKU: GMS-3172
×